海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- GLP-1 and stroke
- Stroke MedDRA version: 19.1 Level: PT Classification code 10061256 Term: Ischaemic stroke System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Denmark
- 2016-03-22
Authorised
- Pembrolizumab as First Line Treatment in Subjects with Recurrent/Metastatic HNSCC.
- Recurrent/metastatic head and neck squamous cell carcinoma. MedDRA version: 20.0 Level: PT Classification code 10071540 Term: Head and neck cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10067821 Term: Head and neck cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, Finland, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Latvia, Malaysia, Mexico, Netherlands, Norway, Peru, Philippines, Poland, Romania, Russian Federation, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, United States
- 2014-12-22
Authorised
- Rituximab as first-line therapy in lupus nephritis
- Lupus Nephritis MedDRA version: 19.1 Level: PT Classification code 10025140 Term: Lupus nephritis System Organ Class: 10038359 - Renal and urinary disorders ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Belgium
- 2017-04-21
Authorised
- Untersuchungen zur antipsoriatischen Wirkung der UVB-induzierten Synthese von 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol) in Keratinozyten läsionaler psoriatischer Haut unter Verwendung des Cytochrom-P (CYP) Inhibitors Ketokonazol - VITAKET
- Hauptzielvariable ist die klinische Beurteilung der chronisch stationären Psoriasis vulgaris durch den intraindividuellen Vergleich der unterschiedlich behandelten Felder (Feld 1: UVB-Bestrahlung + adäquate, wirkstofffreie Grundlage Nizoral Creme) (Feld 2: UVB-Bestrahlung + Nizoral Creme)( Feld 3: unbehandelt) auf der Grundlage des lokalen PASI-Scores. Unterstützend werden hier die objektiven Parameter OCT und Ultraschall eingesetzt.
- Germany
- 2008-06-19
Authorised
- Study of oral PHA-848125AC in patients with malignant thymoma previously treated with multiple lines of chemotherapy
- Recurrent or metastatic, unresectable B3 thymoma or thymic carcinoma previously treated with multiple lines of chemotherapy;Therapeutic area: Diseases [C] - Cancer [C04]
- Italy, United States
- 2013-02-27
Authorised
- Pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen as first line treatment for R/M HNSCC (KEYNOTE-669/ECHO-304)
- Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Brazil, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-10-24
Authorised
- Pembrolizumab (MK-3475) as First-Line Therapy for Advanced Merkel Cell Carcinoma
- Unresectable Stage III and Stage IV Merkel Cell Carcinoma (MCC) MedDRA version: 20.0 Level: LLT Classification code 10064025 Term: Merkel cell carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, France, Italy, New Zealand, Spain, Sweden, United States
- 2018-10-24
Authorised
- First-line chemotherapy plus pembrolizumab and olaparib for BRCA non-mutated advanced EOC
- Advanced epithelial ovarian cancer MedDRA version: 20.0 Level: PT Classification code 10033128 Term: Ovarian cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2018-10-23
Authorised
- 4 - weeks, double blind, parallel, randomized study: Comparison of repetitive transcranial magnetic stimulation (rTMS) and venlafaxine (Effectin ER) in the treatment of resistant depressive disorder - D-RTMS-VEN
- Rezistentní depresivní porucha, tj. depresivní porucha, která nedostatecne odpovedela 1. lécebný pokus antidepresivem
- Czech Republic
- 2005-04-04
Authorised
- A comparison of pharmacodynamics and pharmacokinetics of Insulin Aspart and Biphasic Insulin Aspart 30, 50 og 70. A quadruple cross-over trial. - Asp-BIAsp-2005/0109
- Patients with type 1 diabetes
- Denmark
- 2008-05-20
